SunGlowInnovations

INVESTIGATIONAL ONCOLOGY

Image-guided
oncology research

SunGlow Innovations LLC is developing CDX-101, an investigational chlorine dioxide injection for image-guided local treatment research in solid tumors.

IMAGE-GUIDED INTRATUMORAL DELIVERY SIMULATED ULTRASOUND GOLDEN ClO₂ SOLUTION TARGET LESION NEEDLE TIP CONCEPTUAL SCHEMATIC
LEAD PROGRAM CDX-101INVESTIGATIONAL PRODUCT Chlorine Dioxide Injection 2%

CDX-101 RESEARCH RATIONALE

Potential to change how cancer is managed

Our view is that a new local treatment mechanism could change how some cancers are managed over time.

Potential for a very high benefit–risk ratio and broad use

Our view is that combining image-guided delivery with a rapidly self-limiting local effect has the potential for a very high benefit–risk ratio. The approach is intended for accessible lesions of diverse extracranial solid tumors, including lesions in breast, head and neck, and cervical cancers.

Phase 1 study plan

An unusual starting point: human data before the IND

Before IND submission, the project had accumulated historical observations from about 25 people. The records describe changes in local tumor tissue and symptoms as well as adverse events, and shaped the clinical development plan.

Human observations

Parallel development for people and companion animals

The project has an uncommon companion-animal case series: 22 animals with spontaneous tumors, including 19 dogs and 3 cats. Veterinary recruitment, imaging and follow-up made these cases difficult to collect. We are pursuing human and veterinary drug development in parallel and see a new local mechanism as a way to widen the few options available in pet oncology.

Companion-animal program

The uncommon path of an inventor-led drug program

The program grew out of an individual inventor’s work on chlorine dioxide technology. Sponsors and collaborating research teams are now taking that work through formulation development, testing and formal clinical planning.

Technology and company background

DEVELOPMENT PORTFOLIO

Global development

View milestones

SCIENCE & TECHNOLOGY

Studying what happens at the lesion

The program studies direct oxidation after local delivery and the hypothesis that changes in microvascular perfusion contribute to downstream tissue effects. The evidence spans laboratory experiments and historical observations.

Ask CDX-101 AI

Ask about the science and see the source behind each response.

About

Explore clinical, veterinary and international research collaboration.